&nbsp;

HTA2018CancerNominationPackage.pdf

Dec 2017

Document

HTA2018CancerNominationPackage-FR.pdf

Dec 2017

Document

HTA2018RenalNominationPackage.pdf

Dec 2017

Document

HTA2018RenalNominationPackage-FR.pdf

Dec 2017

Document

healthWorksLogo.png

Dec 2017

Regimen

HYDR

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL),

Leukemia - Acute Myeloid (AML)

Intent: Palliative

Funding:

ODB - General Benefit

hydroxyurea

Drugs Used:

hydroxyurea

... Show more tags

Quick Link(s):

Regimen Monograph

Mar 2023

Regimen

HYPERCVAD+RITU

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

riTUXimab (Unfunded),

Quick Link(s):

Regimen Monograph

Apr 2022

Regimen

HYPERCVAD+RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade

Intent: Curative

Funding:

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Aggressive Histology Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - HIV-Related Aggressive Histology B-cell Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Aggressive Histology Lymphoma

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - HIV-Related Aggressive Histology B-cell Lymphoma

ODB - General Benefit

dexamethasone

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2022

Document

HTA_resourcehub_hands.jpg

Jan 2018

Document

HTA2018RegionalSocialPostsForCancerNominations.docx

Jan 2018

Document

HTA2018RegionalSocialPostsForKidneyNominations.docx

Jan 2018

Regimen

FLAG

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL),

Leukemia - Acute Myeloid (AML)

Intent: Palliative

Drugs Used:

fludarabine,

cytarabine

... Show more tags